GuideAugust 9, 2026 · 1 min read

AOD-9604: The hGH Fragment 177-191 Lipolytic Peptide

Research compounds for laboratory use only · not medical advice

AOD-9604, the synthetic analog of hGH fragment 177-191, and its research in lipolysis, fat metabolism and growth-hormone fragment pharmacology.

AOD-9604 is an exercise in fragment biology: take a short region of human growth hormone, modify it to shed unwanted activity, and study what the remaining sequence does on its own.

The molecule

AOD-9604 (C₇₈H₁₂₃N₂₃O₂₃S₂, ≈ 1815 g/mol) is a synthetic analog of hGH fragment 177-191 — the C-terminal region of human growth hormone. The analog was modified to remove the diabetogenic activity associated with the full molecule, so that the fragment’s lipolytic signaling can be studied in isolation.

What the research looks at

  • Lipolysis and fat metabolism — the dominant thread; how the fragment signals lipid mobilization
  • Growth-hormone fragment pharmacology — the broader question of which hGH regions carry which activities
  • Metabolic-regulatory signaling — where the fragment sits relative to full-hormone metabolic effects

Handling notes

Lyophilized, reconstitute with bacteriostatic water; the reconstitution calculator handles the math. Store at −20°C lyophilized.

See AOD-9604 for CAS, purity and full specifications.

For laboratory research use only. Not medical advice.

Last updated September 9, 2026

FAQ

Frequently asked questions

What is AOD-9604?

AOD-9604 is a synthetic analog of the C-terminal fragment (177-191) of human growth hormone, modified to remove diabetogenic activity while retaining lipolytic research interest.

What research uses AOD-9604?

Lipolysis and fat-metabolism research, growth-hormone fragment pharmacology, and metabolic-regulatory signaling models.

Why study a growth-hormone fragment?

Certain hGH fragments carry metabolic activity independently of the full hormone. Fragment 177-191 is studied for lipolytic signaling without the broader effects of intact growth hormone.